PROCEEDINGS

Vol. 126 No. 1375 |

Proceedings of the Scientific Meetings of the Health Research Society of Canterbury, 3 & 10 May 2013

Full article available to subscribers

Use of the DISST model to predict insulin pharmaco-kinetics during the oral glucose tolerance test and reduce the cost of deriving the Matsuda index, SM Davidson1, PD Docherty1, JG Chase1, JE Berkeley2; 1Centre for Bioengineering, University of Canterbury, 2Canterbury District Health Board (CDHB)Early detection of Type 2 Diabetes, through the determination of an individuals insulin sensitivity (SI) has the potential prompt intervention that may reduce the incidence of type 2 diabetes and ameliorate the considerable financial strain it places on global health care. Reducing the cost of SI measurements such as the Matsuda and HOMA should allow more widespread screening for pre-diabetes. The goal of this research was to use a model based approach to reduce the number of insulin samples and therefore the cost required to provide an accurate Matsuda index.The Dynamic Insulin Sensitivity and Secretion Test (DISST) model was used with the glucose and basal insulin measurements from an oral glucose tolerance test (OGTT) protocol to predict patient insulin responses (N=50). The insulin response to the OGTT was determined via population based regression analysis that incorporated the 60-minute glucose and basal insulin values.The proposed method derived accurate and precise Matsuda indices as compared to the fully sampled Matsuda using only the basal assay insulin level data and four glucose measurements (R = 0.951). Using a model employing the basal insulin allows for determination of the 1-day HOMA value. The simulated Matsuda index had a median error of 16.5%, minimum of 0.07 % and maximum of 41.9 %. A Bland-Altman Analysis showed no systematic bias in the methods outputs.The DISST model successfully predicted the participants insulin response to the OGTT. In turn, this enabled highly accurate and precise estimation of Matsuda indices using only the glucose and basal insulin assays. As insulin assays account for the majority of the cost of the Matsuda index, this approach offers a significant reduction in assay cost.Calcium role in oxLDL mediated cell death in human monocytes: Possible mechanism in the progression of atherosclerotic plaque, MI Othman, and SP Gieseg, School of Biological Sciences, University of Canterbury, ChristchurchCardiovascular disease is progressive inflammatory disease characterised by the formation of atherosclerotic plaques made up of lipid load macrophages, lipid deposits, fibrous protein and dead cells within the arterial walls. The death of these lipid loads cells by oxidised low density lipoprotein (oxLDL) causes plaque instability, leading to both plaque growth and plaque rupture. The cell death is caused by severe oxidative stress triggered by the oxLDL. The cell death is also associated with a rise in intracellular calcium. This study is examining the source of the calcium rise and whether it is a cause or consequence of the oxidative stress.Human monocytes were used to study the role of calcium in oxLDL-mediated cytotoxicity. Cells were pre-incubated with fluorescent calcium binding probe - Fluo 3-AM before treated with oxLDL. Selected calcium channel blockers specific for plasma membrane, endoplasmic reticulum, mitochondria as well as calcium chelator were tested for their effects on the oxLDL mediated cell death process. The movement of calcium into the cytoplasm and changes in intracellular calcium was measured by flow cytometer using the Fluo 3-AM probe. Cell viability was determined by spectrophotometric measurement of MTT reduction and propidium iodide staining by flow cytometry.Human monocytestreated with oxLDL caused increasing intracellular free calcium. Cells incubated in calcium free media as well as media with calcium developed similar patterns of cell death. Blocking the calcium channels by incubating the cells with different types of inhibitors did not prevent cell death. However, inhibition of the calcium rise by a calcium chelator - EGTA, was able to impede intracellular calcium rise but not cell death.Are you managing your mechanical ventilator correctly? A model-based answer to an on-going question, D Redmond1, S Davidson1, H Laing1, R White1, F Radzi1, N Wang2, S Poole1, R Fernando1, J. Williams1, L Badcock1, E van Drunen1, NS Damanhuri1, YS Chiew1, PD Docherty1, GM Shaw2, JG Chase1; 1Centre of Bioengineering, University of Canterbury, Christchurch, 2Department of Intensive Care, Christchurch Hospital, Christchurch.Ventilation dyssynchrony risks inadequate oxygenation, ventilator associated lung injury, and cardiovascular events. This study analyses the outcome of continuous model-based estimates of patient-specific elastance. Spikes in time-varying respiratory elastance (Edrs) which indicate patient-ventilator dyssynchrony are presented.Retrospective analysis of pressure-volume (PV) data of MV patients in the Christchurch Hospital intensive care unit (ICU) was carried out. Model-based time-varying respiratory elastance (Edrs) was estimated for each breath over 5-48 hours and plotted for the analysis to assess patient-ventilator interaction and quality of MV care. The study and use of the data was approved by the Upper South A Regional Ethics Committee.8 patients were included for the study with median of 17,721 [Interquartile range (IQR): 10,255 - 25,035] breathing cycles analysed. A median of 1,569 (11.3%) [IQR: 941 (3.8%) - 3,582 (15.3%)] of total breathing cycles per patient, were identified as asynchrony events, where significant pressure-volume mismatch occurs. The figure shows periods or events of sharply increased Edrs values randomly occurring throughout the data for an indicative patient. The irregular Edrs values indicate significant asynchrony events.Edrs maps provide clinically useful information in monitoring patient-ventilator interaction. As the Edrs map of a sedated patient is assumed smooth, frequent Edrs spikes indicate patients who might benefit more if sedated and synchronised with the ventilator. Patient-specific model-based MV monitoring could significantly impact how MV care is delivered.Simultaneous discrimination of multiple intrinsic bio-markers in excised atheroma with spectral molecular imaging. RK Panta1, CJ Bateman1, J Healy2, JL Mohr1, N de Ruiter1, AP Butler1,3 NG Anderson1, SP Gieseg2; 1Department of Radiology, University of Otago, Christchurch, New Zealand, 2Free Radical Biochemistry Laboratory, School of Biological Sciences, University of Canterbury, Christchurch, New Zealand, 3European Organisation for Nuclear Research (CERN), Geneva, Switzerland.Spectral molecular imaging is a new x-ray based 3D imaging modality which can specifically identify and measure components of biological tissues due to its high energy and spatial resolution. This high resolution imaging modality can be used for characterisation of human vulnerable plaque by identifying and quantifying its natural biological hallmarks. We aimed to simultaneously discriminate multiple intrinsic biomarkers in ex-vivo vulnerable plaque in the diagnostic energy range (30 keV to 120 keV).A MARSTM small animal spectral molecular imaging scanner incorporating Medipix3RX energy resolved (spectral) photon counting x-ray detectors bonded to GaAs sensor layer with a pixel pitch of 110 \u00b5m was used to acquire energy resolved images of the intact plaques. Multiple projections, with eight lower threshold energies of 30, 35, 40, 45, 50, 60, 70 & 80 KeV at 120 kVp x-ray tube voltage were acquired by placing the Al filter (10 mm) at exit window of x-ray tube. Images were reconstructed with algebraic reconstruction methods. Quantification of calcium deposits and soft tissue components (water-like and lipid-like) were performed by analysing their spectral attenuation profiles using a previously validated constrained least squares material decomposition technique.Calcium and iron, lipid-like, and water-like components of plaque have distinguishable and quantifiable energy responses to x-rays in diagnostic energy range, visible on spectral molecular imaging at 110 \u00b5m spatial resolution.We have demonstrated that multiple intrinsic biomarkers of intact excised vulnerable atherosclerotic plaque can be quantified simultaneously using spectral x-ray molecular imaging at high spatial resolution in the diagnostic energy range. The imaging technique and methodology is likely to be applicable for human imaging.When spectral molecular imaging is available clinically, it could be used to detect vulnerable plaque and to monitor the efficacy of different treatment regimens.Can this cool new glycaemia metric tell me if my critical care patients are going to live or die? F Thomas1, M Signal2, G M Shaw3, J G Chase4; 1Department of Mechanical Engineering, University of Canterbury, New Zealand, 2Department of Mechanical Engineering, University of Canterbury, New Zealand, 3Department of Intensive Care, Christchurch Hospital, Christchurch School of Medicine and Health Science, University of Otago, New Zealand, 4Department of Mechanical Engineering, University of Canterbury, New ZealandCritically ill patients often experience stress-induced hyperglycaemia, which may negatively impact outcomes. Continuous glucose monitoring (CGM) devices measure blood glucose (BG) every 5 minutes and allow researchers to investigate high frequency dynamics, such as glucose complexity.Current theories contend that a healthy glucose regulatory system will make many small adjustments to keep glucose concentration within a normal range, increasing the complexity of CGM data [2, 3]. Two studies have investigated glucose complexity in critically ill patients using Detrended Fluctuation Analysis (DFA) to quantify glucose complexity. Both studies concluded increased complexity was associated with reduced mortality.CGM data from 10 patients admitted to the Christchurch Hospital Intensive Care Unit. Each participant was monitored using 3 CGM devices: 2 located on the patients abdomen, of which 1 was connected to a Medtronic Guardian Real-Time monitor and one connected to a Medtronic iPro2 recorder; and a third located on the patients thigh and connected to a Medtronic iPro2 recorder. This configuration of sensors/devices allowed inter-site and inter-device comparisons. Glucose complexity was quantified using DFA. For a self-similar time series, the scale invariant structure can be described by , where the power law exponent (H) describes the scaling. As in the other published studies, the power law exponent was used as the basis for comparison, where a lower value indicates greater complexity.Retrospectively calibrated iPro2 CGMs reported significantly higher scaling exponents:1.56 [1.46 - 1.60] compared to Guardian Real-Time devices: 1.43 [1.37 - 1.48] (p = 0.03). Scaling exponents of patients who lived were 1.51[1.46 - 1.57] versus 1.47[1.39 - 1.59] for patients who died (p = 0.5). Using prior study results to segregate mortality showed that none of the 8 patients had all 3 CGM devices indicating a single, or correct, outcome.These results show a more significant association between glucose complexity and sensor/device type than between glucose complexity and patient outcome. Further investigations of glucose complexity are required before solid conclusions can be drawn.The impact of physiological levels of vitamin C on tumour growth and HIF-1 activation in the Gulo-/- mouse. E J Campbell1, A Dyer2, BA Robinson3, 4, MCM Vissers1, GU Dachs1.1Department of Pathology, University of Otago, Christchurch, 2 CARA Research Facilities, Department of the Dean, University of Otago, Christchurch, 3Canterbury Regional Cancer and Blood Service, CDHB, Christchurch, 4 Department of Medicine, University of Otago, Christchurch.Vitamin C (ascorbate) is an important co-factor for the hydroxylase enzymes that regulate the transcription factor hypoxia-inducible factor-1 (HIF-1). HIF-1 controls the expression of hundreds of genes involved in tumour growth and spread. Adequate supplementation of cells with ascorbate has been shown to reduce HIF-1activation in vitro, and a similar activity could affect tumour growth in vivo. This study investigated the effect of physiological ascorbate intake on tumour growth in the Gulo-/- knockout mouse, a model of the human ascorbate deficiency condition.C57BL6 Gulo-/- mice were supplemented with optimal (3300 mg/L), medium (330 mg/L) or low (33mg/L) ascorbate in their drinking water for one month before subcutaneous tumour implantation with B16-F10 melanoma cells (1x106 /mouse), and for the duration of the experiment. Tumour growth was monitored and tumours were excised when they reached ~1000mm3. HIF-1 activation was analysed by western blotting of tissue extracts and ascorbate concentrations in tumours, normal tissues and plasma were analysed using HPLC.Ascorbate concentrations in plasma, tumour and normal tissues were significantly different across the three ascorbate loading treatments. B16-F10 tumours showed no difference in the time taken for tumours to appear from implantation between ascorbate treatments. However, in mice supplemented with optimal ascorbate these tumours grew significantly slower during the log phase compared to tumours grown in mice supplemented with medium or low ascorbate. Tumours grown in mice supplemented with optimal ascorbate had reduced HIF-1 levels compared to medium and low dose tumour-bearing mice. Therefore, this in vivo study suggests that maintenance of tissues at optimal physiological levels of ascorbate is associated with reduced HIF-1 levels and tumour growth in the Gulo-/- mouse model.Cost-effective hemodynamic monitoring of critically ill patients via model-based analysis of aortic pressure measurements. S Kamoi1, D Squire, JG Chase1, PD Docherty1, T Desaive2, 1Centre for Bioengineering, University of Canterbury, Christchurch, 2Faculty of Medicine, University of Liege, Belgium.There are many hemodynamic monitoring systems currently used in the intensive care unit from non-invasive device such as USCOM to semi-invasive device such as PiCCO. These devices are expensive and require frequent repositioning or calibration and thus, introduce clinical burden. These devices determine cardiac output values based on pulse-pressure measurements and patient-specific anatomic parameters. These assumptions lead to ambiguous population-driven estimation of hemodynamic parameters that may not be indicative of the patient state and thus could lead to sub-optimal clinical decisions.Aortic pressure waveforms contain important diagnostic/physiological information and model based analysis of the contour could potentially determine, accurate and reliable continuous stroke volume. To validate the model-based stroke volume form aortic pressure approach, porcine experiments were undertaken by the Medical Faculty at the University of Liege. Anesthetised pig underwent recruitment manoeuvres and had acute respiratory distress syndrome induced via lavage of the lung. Aortic pressure and ventricle volume were measured at 200Hz for 2.5 hours. The Levenberg-Marquardt method was used to identify parameters in the 3-element Windkessel model of aortic pressure-flow dynamics.Bland-Altman analysis between model-based output and measured data shows 95% of the model output results agreed within 11ml with the experimental data with a mean bias of 1ml.Our pulse pressure estimation of stroke volume accurately captured the trends that would be needed to optimise therapy in a critical care setting. Furthermore, the outcomes were entirely data-driven, without the need for population-based anatomic parameters. It is expected that further investigation of the model in post-hoc human data will reveal further insight into the mechanical relationships between resistance and compliance, and would thus, further improve the robustness of our stroke volume estimation.Redirection of steroid biosynthetic flux from testosterone to cortisol in cultured Leydig cells exposed to dibutylphthalate, A D Ridden, I C Shaw, Department of Chemistry, University of Canterbury, Christchurch.NZ Malayan veterans exposed to dibutylphthalate (DBP) during the Malayan Emergency have a higher incidence of cryptorchidism and hypospadias than the general New Zealand population. This might involve epigenetic control of genes that code for enzymes in the testosterone synthetic pathway. In our study we investigated the effect of DBP on R2C rat Leydig cells in culture to determine whether reduced testosterone synthesis might contribute to the developmental effect seen in the veterans.R2C cells were cultured in phenol red-free Eagles Minimum Essential Medium containing 17.5% stripped fetal bovine serum. They were grown to cell concentration 105/mL and exposed to DBP (0.1, 1.0, 5.0, 10.0 \u00b5g/mL) in triplicate. The culture medium containing un-adhered cells was centrifuged and the supernatant (30 mL) extracted with diethyl ether (3 x 60mL). The ether was evaporated in a flow of N2. The residue was dissolved in methanol (1.5 mL) and analysed by high performance liquid chromatography (HPLC). HPLC conditions: C18reverse phase 5\u00b5m column. Mobile phase: stepped gradient; solvent A (0.05% (aq.) w/v trifluoroacetic acid), solvent B (acetonitrile). Gradient details: start 90% A, 10% B (2 min), increased to 45%A, 55% B (2-18 min), held to 34 min. VRs were determined for steroids, including cortisol and testosterone.R2C cells do not synthesise testosterone, but synthesise the metabolic intermediates up to and including progesterone. Exposure of R2C cells to DBP resulted in the synthesis of the glucocorticoid, cortisol in a dose related manner. These results show that DBP causes cortisol biosynthesis in R2C cells which suggest that the steroid biosynthetic flux in DBP-exposed Leydig cells shifts from testosterone to cortisol. This might have significant implications in growth and development in exposed males and could explain the increased incidence of gonadal developmental disorders in DBP exposed veterans.Evaluating BRCA1 and BRCA2 sequence variants that modulate isoform expression, V Lattimore1, M Currie1, B Robinson1,2, KConFab investigators3, A Spurdle4, L Walker1;1Mackenzie Cancer Research Group, Department of Pathology, Otago University Christchurch, New Zealand, 2Department of Medicine, University of Otago, Christchurch and Oncology Services, Christchurch Hospital, Christchurch, New Zealand. 3Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Victoria, Australia, 4Genetics and Computational Biology Division, Queensland Institute of Medical Research, Queensland, Australia.Routine diagnostic BRCA1 and BRCA2 gene screening is typically performed for individuals from high-risk breast-ovarian families. BRCA1/2 sequence variants in or near splice sites and splicing regulatory regions may result in a disruption of the mRNA splicing process. However, the relative level to which mRNA splicing is modulated by common or rare DNA sequence variants in BRCA1/2 has yet to be ascertained. Splicing assays commonly undertaken in the clinical setting to assess the clinical relevance of rare sequence variants in these genes are able to detect the presence of aberrant isoforms and/or the absence of naturally occurring isoforms. However, these assays are limited in their ability to quantify allele-specific expression changes in BRCA1/2 isoforms that may be associated with cancer risk. Our study aims to generate a comprehensive expression profile of BRCA1/2 isoforms and use these data to measure allele-specific expression changes of risk-assessed rare and common variants in BRCA1/2.We have performed bioinformatic splicing analysis on all common single nucleotide polymorphisms across BRCA1/2 using tools including Human Splicing Finder, MaxEnt and ESE Finder. We also performed these analyses on 84 rare variants that were submitted for assessment of breast cancer risk to the large Collaborative Oncological Gene-environment Study (COGS). Twenty lymphoblastic cell lines (LCLs) carrying high risk variants predicted to alter splicing, 20 (LCLs) carrying no/low risk variants predicted to alter splicing and 20 (LCLs) from healthy individuals are being identified for in vitro splicing analysis using targeted RNA-seq and qPCR. mRNA isoforms from BRCA1/2 will be comprehensively profiled and the allele-specific expression of each common and rare variant will be measured and correlated with the bioinformatic predictions. This study is designed to better assess BRCA1/2 sequence variants that modulate isoform expression, and elucidate the contribution of BRCA1/2 mRNA isoform dysregulation to breast cancer susceptibility.\r\n